Cancer Biol Ther

• 

  Publication Venue For

  • Drivers of treatment patterns in patients with chronic lymphocytic leukemia stopping ibrutinib or idelalisib therapies..  19:636-643. 2018
  • A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer..  16:678-683. 2015
  • IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition..  16:1029-1041. 2015
  • Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cells..  15:1358-1366. 2014
  • An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo..  15:1280-1291. 2014
  • Identification of repurposed small molecule drugs for chordoma therapy..  14:638-647. 2013
  • Oral paricalcitol (19-nor-1,25-dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer: a feasibility trial..  14:476-480. 2013
  • Metabolic reprogramming of the immune response in the tumor microenvironment..  14:315-318. 2013
  • The Akt signaling pathway: an emerging therapeutic target in malignant melanoma..  12:1032-1049. 2011
  • Bone marrow-derived mesenchymal stem cells undergo JCV T-antigen mediated transformation and generate tumors with neuroectodermal characteristics..  9:286-294. 2010
  • Ligation of cell surface GRP78 with antibody directed against the COOH-terminal domain of GRP78 suppresses Ras/MAPK and PI 3-kinase/AKT signaling while promoting caspase activation in human prostate cancer cells..  9:142-152. 2010
  • Identification of a tumor associated antigen that can induce tumor specific cytotoxicity..  8:844-845. 2009
  • hBub1 negatively regulates p53 mediated early cell death upon mitotic checkpoint activation..  8:548-556. 2009
  • Can you tBID on it?.  7:1723-1725. 2008
  • Targeting cell surface F1F0 ATP synthase in cancer therapy..  7:1836-1838. 2008
  • Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection..  7:353-360. 2008
  • Augmentation of tumor-specific immunity by upregulation of apoptotic melanoma cell calreticulin expression..  11:581-583. 2011
  • Steroid hormones drive cancer development..  10:765-766. 2010